Anti-inflammatory cancer drug could dramatically reduce risk of heart
A drug commonly used to treat kidney cancer could be offered to people who have suffered heart attacks. Researchers have discovered that treating victims with aldesleukin dramatically reduced inflammation in their arteries. It is a normal part of the body’s immune response to injury or infection but it has been linked to an increased risk … Read more
